New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
10:44 EDTRPRXRepros expects to report results for Phase 2 vaginal Proellex study in 1Q13
Sees fully enrolling 1 year Dexa study in Q1. Expects to request Androxal pre-NDA meeting with FDA for 1Q14 in 4Q13. Comments from slides that will be presented at the 2013 Biotech Showcase Conference.
News For RPRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 4, 2014
08:44 EDTRPRXRepros Therapeutics management to meet with Brean Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use